These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30281408)

  • 1. Mir-206 partially rescues myogenesis deficiency by inhibiting CUGBP1 accumulation in the cell models of myotonic dystrophy.
    Dong W; Chen X; Wang M; Zheng Z; Zhang X; Xiao Q; Peng X
    Neurol Res; 2019 Jan; 41(1):9-18. PubMed ID: 30281408
    [No Abstract]   [Full Text] [Related]  

  • 2. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity.
    Peng X; Shen X; Chen X; Liang R; Azares AR; Liu Y
    Biochim Biophys Acta; 2015 Jul; 1852(7):1490-7. PubMed ID: 25887157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-322/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats.
    Shen X; Xu F; Li M; Wu S; Zhang J; Wang A; Xu L; Liu Y; Zhu G
    Cell Death Dis; 2020 Oct; 11(10):891. PubMed ID: 33093470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-322/miR-503 clusters regulate defective myoblast differentiation in myotonic dystrophy RNA-toxic by targeting Celf1.
    Dong W; Liu Q; Wang ZC; Du XX; Liu LL; Wang N; Weng JF; Peng XP
    Toxicol Res (Camb); 2021 Jan; 10(1):29-39. PubMed ID: 33613970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.
    Amack JD; Reagan SR; Mahadevan MS
    J Cell Biol; 2002 Nov; 159(3):419-29. PubMed ID: 12427866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.
    Timchenko L
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation.
    Amack JD; Mahadevan MS
    Hum Mol Genet; 2001 Sep; 10(18):1879-87. PubMed ID: 11555624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1.
    Salisbury E; Sakai K; Schoser B; Huichalaf C; Schneider-Gold C; Nguyen H; Wang GL; Albrecht JH; Timchenko LT
    Exp Cell Res; 2008 Jul; 314(11-12):2266-78. PubMed ID: 18570922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain.
    Wang PY; Kuo TY; Wang LH; Liang WH; Wang GS
    Acta Neuropathol Commun; 2023 Mar; 11(1):44. PubMed ID: 36922901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.
    Kuyumcu-Martinez NM; Wang GS; Cooper TA
    Mol Cell; 2007 Oct; 28(1):68-78. PubMed ID: 17936705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
    Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
    J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-1 by nonsteroidal anti-inflammatory drugs demethylates MeR2 enhancer and promotes Mbnl1 transcription in myogenic cells.
    Huang K; Masuda A; Chen G; Bushra S; Kamon M; Araki T; Kinoshita M; Ohkawara B; Ito M; Ohno K
    Sci Rep; 2020 Feb; 10(1):2558. PubMed ID: 32054946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.
    Picchio L; Legagneux V; Deschamps S; Renaud Y; Chauveau S; Paillard L; Jagla K
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
    Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
    Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1.
    Wei C; Stock L; Valanejad L; Zalewski ZA; Karns R; Puymirat J; Nelson D; Witte D; Woodgett J; Timchenko NA; Timchenko L
    FASEB J; 2018 Apr; 32(4):2073-2085. PubMed ID: 29203592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy.
    Zhang L; Lee JE; Wilusz J; Wilusz CJ
    J Biol Chem; 2008 Aug; 283(33):22457-63. PubMed ID: 18559347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.